Haven: That’s the Name of Atul Gawande’s Grand Experiment

Information formally released about Amazon, Berkshire Hathaway, and JPMorgan Chase’s effort to transform health care.

MANAGED CARE has been writing about disruptive innovation for a long time. Possibly what will become one of the most disruptive innovations finally got a name yesterday: Haven. This is the company being headed by Atul Gawande, MD, and funded by Amazon, Berkshire Hathaway, and JPMorgan Chase.

The company launched a website and plans to open an office in New York City (Haven is based in Boston). In a letter posted on the website, Gawande promise: “We will be relentless. We will insure our work has high impact and is sustainable.”

This is the first information willingly released by Haven since the enterprise was launched in January 2018. Some other info was made public thanks to a lawsuit brought by Optum, which is concerned that one of its former top dogs who’d jumped ship to Haven is taking some proprietary information with him along for the ride.

Stat reports that “the case revealed the concern health industry incumbents have about Haven’s potential to disrupt their business, and testimony in the suit offered early hints about the venture’s efforts to make health insurance more intelligible and basic services more attainable.”